<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/SAMe.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:08 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2907000">
<meta name="Category" content="Supp">
<meta name="Article" content="SAMe">
<title>S-Adenosilmetionina-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">SAMe</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="SAMe.htm">Volver al art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Chiang PK, Gordon RK, Tal J, et al. S-Adenosylmethionine and methylation. <em>
FASEB J</em> 1996;10:471&#8211;80 [review].</li>

<li class="Ref">Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine
(S-adenosylmethionine) in neurological disorders. <em>Drugs</em> 1994;48:137&#8211;52
[review].</li>

<li class="Ref">Fava M, Rosenbaum JF, MacLaughlin R, et al. Neuroendocrine effects of
S-adenosyl-L-methionine, a novel putative antidepressant. <em>J Psychiatr Res</em>
1990;24:177&#8211;84.</li>

<li class="Ref">Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood levels in
major depression: changes with drug treatment. <em>Acta Neurol Scand</em>
1994;154(suppl):15&#8211;8.</li>

<li class="Ref">Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood levels in
major depression: changes with drug treatment. <em>Acta Neurol Scand</em>
1994;154(suppl):15&#8211;8.</li>

<li class="Ref">Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: Meta-analysis of
clinical studies<em>. Acta Neurol Scand</em> 1994;154(suppl):7&#8211;14.</li>

<li class="Ref">Salmaggi P, Bressa GM, Nicchia G, et al. Double-blind, placebo-controlled
study of s-adenosyl-methionine in depressed post-menopausal women. <em>Psychother
Psychosom</em> 1993;59:34&#8211;40.</li>

<li class="Ref">Kagan BL, Sultzer DL, Rosenlicht N, et al. Oral S-adenosyl-methionine in
depression: A randomized, double-blind, placebo-controlled trial. <em>Am J Psychiatry</em>
1990;147:591&#8211;5.</li>

<li class="Ref">Fava M, Rosenbaum JF, Birnbaum R, et al. The thyrotropin-releasing hormone as
a predictor of response to treatment in depressed outpatients. <em>Acta Psychiatr Scand</em>
1992;86:42&#8211;5.</li>

<li class="Ref">De Vanna M, Rigamonti R. Oral S-adenosyl-L-methionine in depression. <em>Curr
Ther Res</em> 1992;52:478&#8211;85.</li>

<li class="Ref">Fava M, Giannelli A, Rapisarda V. Rapidity of onset of the antidepressant
effect of parenteral S-adenosyl-L-methionine. <em>Psychiatr Res</em> 1995;56:295&#8211;7.</li>

<li class="Ref">Schumacher HR. Osteoarthritis: The clinical picture, pathogenesis, and
management with studies on a new therapeutic agent, S-adenosylmethionine. <em>Am J Med</em>
1987;83(suppl 5A):1&#8211;4 [review].</li>

<li class="Ref">Harmand MF, Vilamitjana J, Maloche E, et al. Effects of S-adenosylmethionine
on human articular chondrocyte differentiation: an in vitro study. <em>Am J Med</em>
1987;83(suppl 5A):48&#8211;54.</li>

<li class="Ref">Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of ademetionine
vs naproxen in activated gonarthrosis. <em>Int J Clin Pharmacol Ther Toxicol</em>
1989;27:329&#8211;33.</li>

<li class="Ref">Muller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine in
versus ibuprofen in the treatment of osteoarthritis. <em>Am J Med</em> 1987;83(suppl
5A):81&#8211;3.</li>

<li class="Ref">Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine
and indomethacin in the treatment of osteoarthritis. <em>Am J Med</em> 1987;83(suppl
5A):78&#8211;80.</li>

<li class="Ref">Maccagno A. Double-blind controlled clinical trial of oral
S-adenosylmethionine versus piroxicam in knee osteoarthritis. <em>Am J Med</em> 1987;83(suppl
5A):72&#8211;7.</li>

<li class="Ref">Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing
S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease.
<em>Am J Med</em> 1987;83(suppl 5A):66&#8211;71.</li>

<li class="Ref">Marcolongo R, Giordano N, Colombo B, et al. Double-blind multicentre study of
the activity of s-adenosyl-methionine in hip and knee osteoarthritis. <em>Curr Ther Res</em>
1985;37:82&#8211;94.</li>

<li class="Ref">Glorioso S, Todesco S, Mazzi A, et al. Double-blind multicentre study of the
activity of S-adenosylmethionine in hip and knee osteoarthritis. <em>Int J Clin Pharmacol
Res</em> 1985;5:39&#8211;49.</li>

<li class="Ref">Montrone F, Fumagalli M, Sarzi Puttini P, et al. Double-blind study of
S-adenosyl-methionine versus placebo in hip and knee arthrosis. <em>Clin Rheumatol</em>
1985;4:484&#8211;5.</li>

<li class="Ref">Tavoni A, Jeracitano G, Cirigliano G. Evaluation of S-adenosylmethionine in
secondary fibromyalgia: a double-blind study. <em>Clin Exp Rheumatol</em> 1998;16:106&#8211;7
[letter].</li>

<li class="Ref">Tavoni A, Vitali C, Bombardieri S, et al. Evaluation of S-adenosylmethionine
in primary fibromyalgia: a double-blind crossover study. <em>Am J Med</em> 1987;83(suppl
5A):107&#8211;10.</li>

<li class="Ref">Volkmann H, Norregaard J, Jacobsen S, et al. Double-blind, placebo-controlled
cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. <em>
Scand J Rheumatol</em> 1997;26:206&#8211;11.</li>

<li class="Ref">Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral S-adenosylmethionine in
primary fibromyalgia: double-blind clinical evaluation. <em>Scand J Rheumatol</em>
1991;20:294&#8211;302.</li>

<li class="Ref">Lieber CS. Herman Award lecture, 1993: a personal perspective on alcohol,
nutrition, and the liver<em>. Am J Clin Nutr</em> 1993;58:430&#8211;42 [review].</li>

<li class="Ref">Osman E, Owen JS, Burroughs AK. S-adenosyl-L-methionine&#8211;a new
therapeutic agent in liver disease? <em>Aliment Pharmacol Ther</em> 1993;7:21&#8211;8
[review].</li>

<li class="Ref">Angelico M, Gandin C, Nistri A, et al. Oral S-adenosyl-L-methionine (SAMe)
administration enhances bile salt conjugation with taurine in patients with liver cirrhosis.
<em>Scand J Clin Lab Invest</em> 1994;54:459&#8211;64.</li>

<li class="Ref">Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosyl-methionine in the
symptomatic treatment of intrahepatic cholestasis: a double-blind, placebo-controlled study.
<em>Gastroenterology</em> 1990;99:211&#8211;5.</li>

<li class="Ref">Bombardieri G, Milani A, Bernardi L, Rossi L. Effects of
S-adenosyl-L-methionine (SAMe) in the treatment of Gilbert&#8217;s syndrome. <em>Curr Ther
Res</em> 1985;37:580&#8211;5.</li>

<li class="Ref">Mato JM, C&#225;mara J, Fern&#225;ndez J, et al. S-adenosylmethionine in
alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter
clinical trial. <em>J Hepatol</em> 1999;30:1081&#8211;9.</li>

<li class="Ref">Piacentino R, Malara D, Zaccheo F, et al. Preliminary study of the use of s.
adenosyl methionine in the management of male sterility. <em>Minerva Ginecol</em>
1991;43:191&#8211;3 [in Italian].</li>

<li class="Ref">Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a methyl
donor (S-adenosylmethionine) in migraine: an open clinical trial. <em>Int J Clin Pharmacol
Res</em> 1986;6:15&#8211;7.</li>

<li class="Ref">Ballerini FB, Anguera AL, Alcaraz P, et al. SAM in the management of
postconcussional syndrome. <em>Med Clin (Barc)</em> 1983;80:161&#8211;4.</li>

<li class="Ref">Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine
(S-adenosylmethionine) in neurological disorders. <em>Drugs</em> 1994;48:137&#8211;52
[review].</li>

<li class="Ref">Osman E, Owen JS, Burroughs AK. S-adenosyl-L-methionine&#8211;a new
therapeutic agent in liver disease? <em>Aliment Pharmacol Ther</em> 1993;7:21&#8211;8
[review].</li>

<li class="Ref">Loehrer FM, Angst CP, Haefeli WE, et al. Low whole-blood S-adenosylmethionine
and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease.
<em>Arterioscler Thromb Vasc Biol</em> 1996;16:727&#8211;33.</li>

<li class="Ref">Bottiglieri T, Godfrey P, Flynn T, et al. Cerebrospinal fluid
S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral
S-adenosylmethionine. <em>J Neurol Neurosurg Psychiatry</em> 1990;53:1096&#8211;8.</li>

<li class="Ref">Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of
clinical studies<em>. Acta Neurol Scand</em> 1994;154(suppl):7&#8211;14.</li>

<li class="Ref">Di Padova C. S-adenosyl-methionine in the treatment of osteoarthritis: review
of the clinical studies<em>. Am J Med</em> 1987;83(suppl 5A):60&#8211;4.</li>

<li class="Ref">Carney MWP, Chary TK, Bottiglieri T, et al. The switch mechanism and the
bipolar/unipolar dichotomy<em>. Br J Psychiatry</em> 1989;154:48&#8211;51.</li>

<li class="Ref">Carney MWP, Chary TK, Bottiglieri T, et al. Switch and S-adenosyl-methionine.
<em>Alabama J Med Sci</em> 1988;25:316&#8211;9.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/SAMe.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:08 GMT -->
</html>

